NCT03699345 - CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

August 14, 2019

Study Completion Date

August 20, 2024

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Replacement (TAVR)

TAVR with the Edwards CENTERA THV System and accessories

Trial Locations (11)

Aarhus University Hospital, Skejby, Aarhus

Clinique Pasteur Toulouse, Toulouse

Hospital Universitario Central de Asturias, Oviedo

Johannes Gutenberg Universitaet Mainz, Mainz

Deutsches Herzzentrum Muenchen (DHM), München

Universitair Medisch Centrum Utrecht, Utrecht

Vall d'Hebron University Hospital - Barcelona, Barcelona

Brighton and Sussex University Hospital, Brighton

Royal Victoria Hospital Belfast, Belfast

Queen Elisabeth Hospital Birmingham, Birmingham

Royal Infirmary of Edinburgh, Edinburgh